Xuzhou Medical University
Clinical trials sponsored by Xuzhou Medical University, explained in plain language.
-
Engineered immune cells take on tough leukemia in new trial
Disease control Not yet recruitingThis early-phase study tests a new type of CAR-T cell therapy for adults with acute myeloid leukemia (AML) that has come back or not responded to standard treatments. The therapy uses a patient's own immune cells, modified to better find and attack leukemia cells. The main goal i…
Phase: PHASE1, PHASE2 • Sponsor: Xuzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New imaging agent lets doctors watch Cancer-Fighting cells in action
Knowledge-focused Not yet recruitingThis early study tests a new PET imaging agent called 68Ga-NOTA-BCMA to see if it can safely and accurately show where anti-BCMA CAR-T cells go in the body and how long they last. Ten adults with multiple myeloma who are scheduled for CAR-T therapy will receive the tracer and und…
Phase: EARLY_PHASE1 • Sponsor: Xuzhou Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC